Logo CICANCER

CIC Events

RAS-PI3K signalling regulates myCAF phenotype acquisition to modulate tumour progression 10/07/2025

RAS-PI3K signalling regulates myCAF phenotype acquisition to modulate tumour progression

Marta Alcón — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca)

Dysregulated RNA Splicing targets Cancer by Proteotoxic Stress. 14/07/2025

Dysregulated RNA Splicing targets Cancer by Proteotoxic Stress.

Cristian Prieto — IBCII - Univ. Frankfurt

Precision Biology for Precision Medicine: Cancer Genomics in Hematological Malignancies 17/07/2025

Precision Biology for Precision Medicine: Cancer Genomics in Hematological Malignancies

Xosé S. Puente — IUOPA-Universidad de Oviedo



Past Events

Uncovering cancer vulnerabilities through novel non-coding, multidimensional, and phenotypic screening technologies 07/07/2025

Uncovering cancer vulnerabilities through novel non-coding, multidimensional, and phenotypic screening technologies

Juan José Montero Valderrama — Institute of Molecular Oncology and Functional Genomics (IMO), Technical University of Munich (TUM). Munich

The long journey to develop a drug against an “undruggable” target in cancer 03/07/2025

The long journey to develop a drug against an “undruggable” target in cancer

Laura Soucek — Vall d´Hebron, Barcelona

Antibody-Drug Conjugates Targeting EGFR in  Ovarian Cancer 30/06/2025

Antibody-Drug Conjugates Targeting EGFR in Ovarian Cancer

Sheila Almaraz — Centro de Investigación del Cáncer (Universidad de Salamanca - CSIC)

Structure of Centromeric Chromatin and Its Consequences for Genome Stability 19/06/2025

Structure of Centromeric Chromatin and Its Consequences for Genome Stability

Carlos Sacristán López — Hubrecht Institute, Utrech (Netherlands)